• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE)
have changed significantly since the Duke Criteria were published in 1994 and modified in …

Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Valvular heart disease is a rapidly growing cause of global cardiovascular morbidity and
mortality with diverse and evolving geographic distribution. The prevalence of rheumatic …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Compared with the extensive data on left‐sided infective endocarditis (IE), there is much
less published information on the features and management of right‐sided IE. Right‐sided …

Background: Streptococci frequently cause infective endocarditis (IE), yet the prevalence of
IE in patients with bloodstream infections (BSIs) caused by different streptococcal species is …

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in
cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Aim Fatality of infective endocarditis (IE) is high worldwide, and its diagnosis remains a
challenge. The objective of the present study was to compare the clinical characteristics and …